Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhang, Zhiqing
NCT06083623: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants	Not yet recruiting	2b	2250	RoW	TNM001, placebo	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Respiratory Syncytial Virus Infections	05/26	08/26
NCT05630573: A Study of TNM001 in Chinese Healthy Preterm and Term Infants	Completed	1/2	31	RoW	TNM001, Placebo	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Respiratory Syncytial Virus Infections	06/23	06/23
TQB3455-I-01, NCT06550713: A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies	Recruiting	1	100	RoW	TQB3455 tablet+Azacitidine for Injection	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)	12/25	12/26